期刊文献+

淫羊藿苷促进白血病K562细胞凋亡的研究 被引量:1

Icaritin promotes the apoptosis of leukemia K562 cells
原文传递
导出
摘要 目的探讨淫羊藿苷对人慢性粒细胞白血病K562细胞的作用及其机制。方法将对数生长期K562细胞分成对照组和淫羊藿苷处理组。对照组细胞常规培养,淫羊藿苷处理组加入8μmol/L淫羊藿苷培养。应用四甲基偶氮唑盐(MTT)法检测K562细胞增殖,流式细胞术检测细胞凋亡,反转录聚合酶链反应(RT-PCR)检测细胞p85、AktmRNA的表达,Westernblot检测p85、Akt、p-p85、D—Akt、cleavage—caspase-3、caspase.3蛋白表达的变化。结果与对照组比较,淫羊藿苷处理组K562细胞增殖率明显下降(P〈0.05),K562细胞凋亡率和p85、Akt、cleavage—caspase-3蛋白表达均明显升高(均P〈0.05),p85mRNA、AktmRNA、caspase-3蛋白表达水平差异均无统计学意义(均P〉0.05)。结论淫羊藿苷能抑制K562细胞增殖,促进其凋亡,其作用机制可能是通过激活P13K—Akt信号转导通路实现的。 Objective To investigate the effect and mechanism of the icaritin on the human cronic myeloid leukemia K562 cells. Methods The K562 cells at logarithmic growth phase were divided into the control group and the icaritin group. The cells in the control group were normally treated and the cells in the icaritin group were incubated with 8 μmol/L icaritin. Methyl thiazolyl tetrazolium (MTT) method and flow eytometry were used to examine the proliferation and apoptotic changes in the two groups after incubation for 72 h, respectively. Gene expression of p85 and Akt were detected by RT-PCR. The protein changes of p85, Akt, p-p85, p-Akt eleavage-caspase-3 and caspase-3 were detected by Western blot. Results Compared with the control group, the proliferation rate of K562 cells in the icaritin group was significantly decreased (P 〈 0.05), however the apoptotic rate of K562 cells and the expressions of p-p85, p-Akt, cleavage-caspase-3 in the icaritin group were significantly increased (all P 〈 0.05), but the expressions of p85 mRNA, Akt mRNA and easpase-3 protein had no difference (all P 〉 0.05). Conclusion Icaritin could induce the proliferation and promote the apoptosis of K562 cell, and its mechanism may be achieved through activating the PI3K-Akt signal transduction pathway.
作者 潘莉萍 袁伟
出处 《白血病.淋巴瘤》 CAS 2016年第6期340-343,共4页 Journal of Leukemia & Lymphoma
关键词 白血病 淫羊藿 K562细胞 细胞增殖 细胞凋亡 PI3K-AKT信号通路 Leukemia Icaritin K562 cells Proliferation Apoptosis PI3k-Akt signal pathway
  • 相关文献

参考文献9

  • 1Li C, Li Q, Mei Q, et al. Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii [J]. Life Sci, 2015, 126: 57-68. DOI:lO.1016/j.lfs. 2015.01.006.
  • 2Sun F, Indran IR, Zhang ZW, et al. A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants [J ]. Carcinogenesis, 2015, 36 (7): 757-768. DOI:lO.1093/carcin/ bgv040.
  • 3Raj TA, Smith AM, Moore AS. Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [ J ]. Int J Nanomedicine, 2013, 8 : 4361-4369. DOI: 10.2147/IJN.$54657.
  • 4廖晖,Jacob Rajfer.经NO-cGMP-PDE5通路治疗勃起功能障碍的中药研究进展[J].中华男科学杂志,2012,18(3):260-265. 被引量:16
  • 5Smolewski P, Witkowska M, Korycka-Wotowiec A. New insights into biology, prognostic factors, and current therapeutic strategies in chronic lymphocytic leukemia [ J ]. ISRN Oncol, 2013, 2013 : 740615. DOI: 10.1155/2013/740615.
  • 6Sami A, Karsy M. Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding [ J ]. Tumour Biol, 2013, 34 ( 4 ) : 1991-2002. DOI : 10.1007/s13277-013-0800-5.
  • 7Martelli AM, Chiarini F, Evangelisti C, et al. Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of raparnycin as a therapeutic strategy for acute leukemia treatment [J]. Oneotarget, 2012, 3 (4): 371-394. DOI: 10.18632/oncotarget.477.
  • 8Layton Tovar CF, Mendieta Zer6n H. Intracellular signaling pathways involved in childhood acute lymphoblastic leukemia; molecular targets [ J ]. Indian J Hematol Blood Transfus, 2016, 32 ( 2 ) : 141- 153. DOI: 10.1007/s12288-015-0609-z.
  • 9Brown JR. The PI3K pathway: clinical inhibition in chronic lymphocytic leukemia [ J ]. Semin Oncol, 2016, 43 ( 2 ) : 260-264. DOI: 10.1053/j.seminoncol.2016.02.004.

二级参考文献29

共引文献15

同被引文献16

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部